Stay informed with the latest data on measles and rubella cases worldwide with this report. Surveillance data, epidemiologic data, and laboratory reports are analyzed and updated monthly. For accurate and up-to-date information on the global status of measles and rubella, access this report. To rece

8 views • 63 slides

The Global Measles and Rubella Report provides provisional data on the reported cases of measles and rubella, distributed monthly via email. Official numbers are available in July each year through the WHO/UNICEF annual data collection. The report is based on surveillance data from Member States, wi

7 views • 62 slides

Measles, mumps, and rubella are infectious diseases with serious consequences. The MMR vaccine is crucial for protection. As MMR vaccine coverage declines, there is a National MMR Call and Recall initiative in February and March 2024. General practices are advised to prepare for patient enquiries, c

3 views • 4 slides

Vaccines play a crucial role in safeguarding individuals of all ages from various diseases, preventing illness, and saving lives. From childhood to old age, staying up-to-date with vaccinations is vital for personal protection, community immunity, and global health. Vaccination against diseases like

0 views • 9 slides

The Measles and Rubella Initiative's Financial Resource Requirements for 2015-2020 were developed to support the Global Measles & Rubella Strategic Plan. The estimated budget is $2.6 billion for 2015-2020, focusing on controlling measles, rubella, and CRS in 77 countries. The costs are categorized i

0 views • 13 slides

WHO and UNICEF have set ambitious goals for eliminating measles and rubella, emphasizing the importance of routine immunization. Progress is tracked through reported cases, vaccine coverage, and supplementary immunization activities (SIAs) in various countries of the Western Pacific Region from 2000

0 views • 20 slides

The WHO European Region has been making significant progress towards eliminating measles and rubella, with 96% reduction in measles and 97% reduction in rubella from 1990 to 2011. Strategies include ensuring high vaccination coverage and conducting supplemental immunization activities in susceptible

0 views • 24 slides

In a measles and rubella meeting in June 2016, Dr. Craig Burgess discussed the impact of Multi-Dose Containers (MDCs) on system performance and cost trade-offs. The phases involved evaluating evidence gaps, considering factors like price per dose, health system impact, and wastage rates. The analysi

0 views • 16 slides

Measles, mumps, and rubella are infectious diseases that can be prevented with the MMR vaccine. The UK is conducting a national MMR call and recall initiative to increase vaccination coverage, especially targeting 6-11-year-olds. General practices are advised to prepare for patient inquiries, check

0 views • 4 slides